Skip to main content

Table 1 Baseline characteristics of TCGA tumor projects included in the study

From: Absence of an embryonic stem cell DNA methylation signature in human cancer

TCGA Tumor Abbreviation

Tumor n

Nontumor normal n

Mean age (sd)

Male n (%)

White n (%)

Black n (%)

Asian n (%)

Other race n (%)

BLCA

418

21

68.60 (10.60)

319 (72.7)

351 (83.6)

25 (6.0)

44 (10.5)

0 (0.0)

BRCA

791

97

58.72 (13.34)

9 (1.0)

668 (76.6)

164 (18.8)

39 (4.5)

1 (0.1)

CESC

307

23

48.77 (13.79)

0 (0.0)

213 (77.7)

31 (11.3)

20 (7.3)

10(3.6)

CHOL

36

9

65.07 (12.46)

22 (48.9)

40 (88.9)

2 (4.4)

3 (6.7)

0 (0.0)

COAD

313

38

66.21 (13.21)

188 (53.9)

240 (75.7)

65 (20.5)

11 (3.5)

1 (0.3)

ESCA

185

16

63.41 (11.87)

168 (83.6)

130 (71.8)

5 (2.8)

46 (25.4)

0 (0.0)

GBM

140

140

60.44 (12.72)

81 (58.3)

107 (81.7)

24 (18.3)

0 (0.0)

0 (0.0)

HNSC

528

50

61.54 (11.82)

424 (73.4)

495 (88.1)

54 (9.6)

11 (2.0)

2 (0.4)

KIRC

324

160

62.54 (11.71)

316 (65.3)

421 (88.1)

55 (11.5)

2 (0.4)

0 (0.0)

LIHC

377

50

60.15 (13.79)

285 (66.7)

221 (53.4)

24 (5.8)

167 (40.3)

2 (0.5)

LUAD

473

32

65.37 (10.29)

236 (46.7)

392 (86.2)

57 (12.5)

6 (1.3)

0 (0.0)

LUSC

370

42

68.23 (8.85)

303 (73.5)

308 (90.3)

25 (7.3)

8 (2.3)

0 (0.0)

PAAD

184

10

65.46 (11.10)

108 (55.7)

170 (89.5)

8 (4.2)

12 (6.3)

0 (0.0)

PCPG

148

8

50.94 (3.12)

66 (44.0)

126 (86.3)

14 (9.6)

5 (3.4)

1 (0.7)

PRAD

502

50

61.64 (6.77)

552(100.0)

195 (94.2)

10 (4.8)

2 (1.0)

0 (0.0)

READ

98

7

63.57 (12.30)

56 (53.8)

76 (92.7)

5 (6.1)

1 (1.2)

0 (0.0)

SARC

261

4

61.52 (14.62)

120 (45.3)

232 (90.6)

18 (7.0)

6 (2.3)

0 (0.0)

STAD

395

63

65.78 (10.68)

259 (65.2)

255 (71.2)

13 (3.6)

89 (24.9)

1 (0.3)

THCA

507

56

47.64 (15.94)

150 (26.6)

372 (80.7)

33 (7.2)

55 (11.9)

1 (0.2)

UCEC

438

46

64.54 (11.19)

0 (0.0)

318 (72.1)

105 (23.8)

9 (2.0)

9 (2.0)

Total

6795

922

61.85 (13.60)

3730 (48.9)

5330 (80.4)

737 (11.1)

536 (8.1)

28 (0.4)